Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01817335 · ClinicalTrials.gov registry record · NA
Psycho-Educational Program in Increasing Knowledge and Satisfaction and Decreasing Distress in Younger Patients With Cancer Receiving Treatment
A NA study of Malignant Neoplasm and Psychosocial Effects of Cancer and Its Treatment, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT01817335: Completed NA study of Malignant Neoplasm and Psychosocial Effects of Cancer and Its Treatment, sponsored by City of Hope Medical Center.
NCT01817335 is a NA study of Malignant Neoplasm and Psychosocial Effects of Cancer and Its Treatment that has completed, run by City of Hope Medical Center. The registered enrollment target is 22 participants, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01817335, a NA study of Malignant Neoplasm and Psychosocial Effects of Cancer and Its Treatment, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies psycho-educational program in increasing knowledge and satisfaction and decreasing distress in younger patients with cancer receiving treatment. Psycho-educational program may increase knowledge and satisfaction and decrease distress in younger patients with cancer receiving treatment
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER educational intervention
- PROCEDURE psychosocial assessment and care
- OTHER communication skills training
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT01817335 record still lists
NCT01817335 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which questionnaire administration is the first listed.
NCT01817335 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01817335 about?
NCT01817335 is a clinical study titled "Psycho-Educational Program in Increasing Knowledge and Satisfaction and Decreasing Distress in Younger Patients With Cancer Receiving Treatment". This pilot clinical trial studies psycho-educational program in increasing knowledge and satisfaction and decreasing distress in younger patients with cancer receiving treatment. Psycho-educational program may increase knowledge and satisfaction and decrease distress in younger patients with cancer ...
What is the current status of trial NCT01817335?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-08. Estimated completion is 2015-05.
What conditions does trial NCT01817335 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Psychosocial Effects of Cancer and Its Treatment.
What interventions are being tested in trial NCT01817335?
The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER), psychosocial assessment and care (PROCEDURE), communication skills training (OTHER).
Who is sponsoring clinical trial NCT01817335?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01817335 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01817335's enrollment target sits among peer trials
22 50th of 59 higher than 10 of 59 other Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Reproductive Health Program in Patients With Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia